CVS profit beats estimates as high drug prices boost pharmacy business

) reported a higher-than-expected fourth-quarter profit on Wednesday as its stores sold more medicines and the pharmacy benefit management business benefited from higher U.S. prescription drug prices.

The company played down the role of rebate guarantees on a conference call with analysts, and said it expects the issue to be immaterial to earnings as it heads into 2021. The company forecast total adjusted 2020 profit of $7.04 to $7.17 per share. The analysts’ average estimate is $7.15 per share, according to Refinitiv data.

CVS plans to offer less expensive expanded health services such as blood pressure screening and diabetes monitoring in 1,500 stores by 2021. Executives said they could eventually expand the format dubbed HealthHubs to all of its stores.

What is good for the stock market is bad for working people.

$300 EpiPen is just criminal.

And overloading their pharmacists with short staffing and incentive based tasks that causes errors.

Well, as long as CVS is happy.

Indonesia Berita Terbaru, Indonesia Berita utama

Similar News:Anda juga dapat membaca berita serupa dengan ini yang kami kumpulkan dari sumber berita lain.

CVS Health beats on fourth-quarter earnings and revenueCVS Health report Wednesday fiscal fourth-quarter earnings and revenue that beat Wall Street's expectations. Time to buy the stock Face masks and sanitizer gel likely helped sales.....
Sumber: CNBC - 🏆 12. / 72 Baca lebih lajut »

CVS Health and Cisco earnings, Powell's second day on the Hill: 3 things to watch on WednesdayWe'll get earnings from CVS Health and Cisco Systems, as well as Federal Reserve Chairman Jerome Powell's second day of testimony to Congress. I heard Jay Powell on CNBC, I had to kill the sound to stay awake at my desk!
Sumber: CNBC - 🏆 12. / 72 Baca lebih lajut »